Research library
Research guides
Plain-English summaries of the published research behind each compound we supply. Every study is cited and linked. These are educational summaries of third-party literature, not medical advice, and not instructions for use.
- Retatrutide research guide
A plain-English guide to LY3437943: what it is, the three receptor systems, what each trial phase found, and where the evidence stops.
- Tirzepatide research guide
Plain-language notes on LY3298176, the dual GIP + GLP-1 literature, Mounjaro/Zepbound distinction, and lab-only handling boundaries.
- Tesamorelin research guide
Plain-English notes on TH9507 identity, the GHRH receptor pathway, HIV-lipodystrophy trial literature, and lab-only handling boundaries.
- NAD+ research guide
Plain-language notes on NAD+ as a nicotinamide coenzyme, the NAD+/NADH redox pair, NAD-consuming enzyme literature, and lab-only handling boundaries.
- Semax research guide
A plain-English guide to Semax: what it is, why it's studied, what the research has and hasn't shown, and where the evidence stops.
- Selank research guide
A plain-English guide to Selank: what it is, why it is studied, what the research has and has not shown, and where the evidence stops.
- BPC-157 and TB-500 research guide
A plain-English guide to BPC-157 and TB-500 - two separate research peptides studied in tissue-repair research - kept separate, with no combined claim.
- CJC-1295 No DAC and Ipamorelin research guide
A plain-English guide to CJC-1295 (No DAC), Ipamorelin, the with DAC caveat, and the compliance limits around this research set.
- BPC-157 research guide
A plain-English guide to BPC-157: what it is, the tissue-repair research (in cells and animals), and where the human evidence stands.
- GHK-Cu research guide
A plain-English guide to GHK-Cu: what it is, why the body makes it, what the studies looked at, and where the evidence stops.
- TB-500 research guide
A plain-English guide to TB-500: the actin-binding fragment of thymosin beta-4, what's been studied, and why it isn't the same as the full protein.
- MOTS-C research guide
A plain-English guide to MOTS-C: what it is, why mitochondrial-derived peptides matter, what the cited studies looked at, and where the evidence stops.
How we produce these guides
- Who writes them
- These guides are written and maintained in-house by the Form Laboratories research team. They are not authored by a named clinician, and nothing in them is medical advice. Where a guide is short, that is because the published research is thin - we would rather say so than fill the space.
- What they are built from
- Each guide summarises published, peer-reviewed literature. Every study we describe is listed in full at the bottom of the page with a link to the original paper, so you can open it and check what it actually says. Form Laboratories did not run any of the cited studies.
- What they deliberately leave out
- These guides describe how the biology works and what the published research measured. They do not contain dosing, preparation, reconstitution or administration instructions, and they make no claim about what any compound would do for a person. Everything we supply is research-use-only reference material.
- How we handle uncertainty
- Where the evidence is limited to cell cultures or animals, we say so in the study entry rather than implying a human result. Where a compound has no completed human trial, the guide states that plainly.
